Oculis management commentary attributes narrower nine-month 2026 loss to warrant valuation and currency gains
OCS•Oculis reported a 24% narrower net loss of CHF 57.06 million for the nine months ended September 30, 2026, driven by warrant valuation gains and favorable currency movements. Operating cash outflow rose 10% to CHF 54.53 million, while cash and short-term financial assets totaled CHF 210.3 million.
1. Nine-month results
Oculis reported a net loss of CHF 57.06 million for the nine months ended September 30, 2026, 24% narrower than a year earlier. Warrant valuation gains and favorable currency movements drove the improvement, outweighing higher operating expenses. General and administrative expenses rose 39% to CHF 25.08 million, primarily reflecting higher share-based compensation, while research and development expenses increased 1% to CHF 44.38 million. Operating cash outflow increased 10% to CHF 54.53 million; cash, cash equivalents and short-term financial assets totaled CHF 210.3 million.
